GlycoMimetics

-$0.08 (-3.07%) Today
+$0.01 (+0.40%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell GlycoMimetics and other stocks, options, and ETFs commission-free!

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.

CEO
Rachel K. King
Employees
54
Headquarters
Rockville, Maryland
Founded
2003
Market Cap
136.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
989.67K
High Today
$2.64
Low Today
$2.48
Open Price
$2.61
Volume
366.74K
52 Week High
$5.19
52 Week Low
$2.37

GLYC Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 30, Pre-Market

You May Also Like

ONEO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure